Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Signal Transduction Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Signal Transduction Inhibitorsmarket, defines the market attractiveness level of Signal Transduction Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Signal Transduction Inhibitors industry, describes the types of Signal Transduction Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Signal Transduction Inhibitors market and the development prospects and opportunities of Signal Transduction Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Signal Transduction Inhibitors market in Chapter 13.
By Player:
AstraZeneca
Amgen
Pfizer
Bristol-Myers Squibb
Roche
GSK
Novartis
By Type:
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib
By End-User:
Hospital Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Signal Transduction Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Signal Transduction Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Signal Transduction Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Signal Transduction Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Signal Transduction Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Signal Transduction Inhibitors Consumption (2017-2022)
-
7.2 United States Signal Transduction Inhibitors Consumption (2017-2022)
-
7.3 Europe Signal Transduction Inhibitors Consumption (2017-2022)
-
7.4 China Signal Transduction Inhibitors Consumption (2017-2022)
-
7.5 Japan Signal Transduction Inhibitors Consumption (2017-2022)
-
7.6 India Signal Transduction Inhibitors Consumption (2017-2022)
-
7.7 South Korea Signal Transduction Inhibitors Consumption (2017-2022)
8 Region and Country-wise Signal Transduction Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Signal Transduction Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Signal Transduction Inhibitors Consumption Forecast (2022-2028)
9 Global Signal Transduction Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Signal Transduction Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dasatinib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Erlotinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gefitinib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Imatinib Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lapatinib Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Nilotinib Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Pazopanib Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Sorafenib Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Sunitinib Consumption and Growth Rate (2017-2022)
-
9.2 Global Signal Transduction Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Signal Transduction Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Signal Transduction Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dasatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Erlotinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gefitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Imatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Nilotinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Pazopanib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Sunitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Signal Transduction Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Signal Transduction Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Signal Transduction Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Signal Transduction Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Signal Transduction Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Signal Transduction Inhibitors Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Signal Transduction Inhibitors Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Signal Transduction Inhibitors Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Signal Transduction Inhibitors Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Signal Transduction Inhibitors Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Signal Transduction Inhibitors Product and Service
-
14.6 GSK
-
14.6.1 GSK Company Details
-
14.6.2 GSK Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GSK Signal Transduction Inhibitors Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Signal Transduction Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Signal Transduction Inhibitors
-
Figure Signal Transduction Inhibitors Picture
-
Table Global Signal Transduction Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Signal Transduction Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Signal Transduction Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Signal Transduction Inhibitors Consumption by Country (2017-2022)
-
Figure United States Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Signal Transduction Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Signal Transduction Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Signal Transduction Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dasatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Erlotinib Consumption and Growth Rate (2017-2022)
-
Figure Global Gefitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Imatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Lapatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Nilotinib Consumption and Growth Rate (2017-2022)
-
Figure Global Pazopanib Consumption and Growth Rate (2017-2022)
-
Figure Global Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Sunitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Dasatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erlotinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gefitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nilotinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pazopanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sunitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Signal Transduction Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Signal Transduction Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Signal Transduction Inhibitors Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Signal Transduction Inhibitors Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Signal Transduction Inhibitors Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Signal Transduction Inhibitors Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Signal Transduction Inhibitors Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Signal Transduction Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Signal Transduction Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Signal Transduction Inhibitors Product and Service
-
